{"id":702415,"date":"2022-10-27T18:44:05","date_gmt":"2022-10-27T22:44:05","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-weiss-law-reminds-sbtx-rmed-rcor-and-btrs-shareholders-about-its-ongoing-investigations\/"},"modified":"2022-10-27T18:44:05","modified_gmt":"2022-10-27T22:44:05","slug":"shareholder-alert-weiss-law-reminds-sbtx-rmed-rcor-and-btrs-shareholders-about-its-ongoing-investigations","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-weiss-law-reminds-sbtx-rmed-rcor-and-btrs-shareholders-about-its-ongoing-investigations\/","title":{"rendered":"SHAREHOLDER ALERT: Weiss Law Reminds SBTX, RMED, RCOR, and BTRS Shareholders About Its Ongoing Investigations"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">NEW YORK<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Oct. 27, 2022<\/span><\/span> \/PRNewswire\/ &#8212;\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/1424445\/WeissLaw_LLP_Logo.html\" target=\"_blank\" rel=\"nofollow noopener\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/1424445\/WeissLaw_LLP_Logo.jpg\" title=\"(PRNewsfoto\/WeissLaw LLP)\" alt=\"(PRNewsfoto\/WeissLaw LLP)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>\n        <b><br \/>\n          <u>If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact:<\/u><br \/>\n        <\/b>\n      <\/p>\n<p class=\"prntac\">\n        <b><br \/>\n          <span class=\"xn-person\">Joshua Rubin, Esq.<\/span><br \/>\n          <br \/>\n        <\/b>Weiss Law<br \/>305 Broadway, 7th Floor<br \/><span class=\"xn-location\">New York, NY<\/span> 10007<br \/><b>(212)\u00a0682-3025<br \/><\/b><b>(888) 593-4771<br \/><u><a href=\"mailto:stockinfo@weisslawllp.com\" target=\"_blank\" rel=\"nofollow noopener\">stockinfo@weisslawllp.com<\/a><\/u><\/b><\/p>\n<p>\n        <b>Silverback Therapeutics, Inc. (NASDAQ: SBTX)<\/b>\n      <\/p>\n<p>Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of <b>Silverback Therapeutics, Inc. (NASDAQ: SBTX)<\/b>, in connection with SBTX&#8217;s proposed merger with ARS Pharmaceuticals, Inc. (&#8220;ARS&#8221;). Under the terms of the merger agreement, assuming that SBTX&#8217;s net cash at closing is <span class=\"xn-money\">$240 million<\/span>, SBTX\u00a0equity holders are expected to own only approximately 37% of the combined company and pre-merger ARS equity holders are expected to own approximately 63% of the combined company. If you own SBTX shares and wish to discuss this investigation or your rights, please call us or visit our website: <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3691592-1&amp;h=22533686&amp;u=https%3A%2F%2Fwww.weisslaw.co%2Fnews-and-cases%2Fsbtx&amp;a=https%3A%2F%2Fwww.weisslaw.co%2Fnews-and-cases%2Fsbtx\" target=\"_blank\" rel=\"nofollow noopener\">https:\/\/www.weisslaw.co\/news-and-cases\/sbtx<\/a><\/p>\n<p>\n        <b>Ra Medical Systems, Inc. (NYSE: RMED)<\/b>\n      <\/p>\n<p>Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors <b>Ra Medical Systems, Inc. (NYSE: RMED<\/b>) in connection with the proposed merger of the Company with Catheter Precision, Inc. (&#8220;Catheter Precision&#8221;). The Merger is structured as a stock for stock reverse merger whereby all of Catheter Precision&#8217;s outstanding convertible promissory notes and equity interests are to be exchanged for shares of RMED common stock and Catheter Precision options assumed by RMED. If you own RMED\u00a0shares and wish to discuss this investigation or your rights, please call us or visit our website: <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3691592-1&amp;h=3010346872&amp;u=https%3A%2F%2Fwww.weisslaw.co%2Fnews-and-cases%2Frmed&amp;a=https%3A%2F%2Fwww.weisslaw.co%2Fnews-and-cases%2Frmed\" target=\"_blank\" rel=\"nofollow noopener\">https:\/\/www.weisslaw.co\/news-and-cases\/rmed<\/a><\/p>\n<p>\n        <b>Renovacor, Inc. (NYSE: RCOR)<\/b>\n      <\/p>\n<p>Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of <b>Renovacor, Inc. (NYSE: RCOR)<\/b>, in connection with the proposed acquisition of RCOR by Rocket Pharmaceuticals, Inc. (&#8220;Rocket Pharmaceuticals&#8221;). Under the terms of the merger agreement, RCOR shareholders will receive 0.1676 shares of Rocket Pharmaceuticals common stock\u00a0for each RCOR share owned, representing implied per-share merger consideration of approximately <span class=\"xn-money\">$2.60<\/span> based upon Rocket Pharmaceuticals&#8217; <span class=\"xn-chron\">October 3, 2022<\/span> closing price of <span class=\"xn-money\">$15.50<\/span>. If you own RCOR shares and wish to discuss this investigation or your rights, please call us or visit our website: <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3691592-1&amp;h=4049241810&amp;u=https%3A%2F%2Fwww.weisslaw.co%2Fnews-and-cases%2Frcor&amp;a=https%3A%2F%2Fwww.weisslaw.co%2Fnews-and-cases%2Frcor\" target=\"_blank\" rel=\"nofollow noopener\">https:\/\/www.weisslaw.co\/news-and-cases\/rcor<\/a><\/p>\n<p>\n        <b>BTRS Holdings Inc. (NASDAQ: BTRS)<\/b>\n      <\/p>\n<p>Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of <b>BTRS Holdings Inc. (NASDAQ: BTRS)<\/b> in connection with the proposed acquisition of BTRS by EQT X fund. Under the terms of the merger agreement, the Company&#8217;s shareholders will receive <span class=\"xn-money\">$9.50<\/span> in cash for each share of BTRS common stock owned. If you own BTRS\u00a0shares and wish to discuss this investigation or your rights, please call us or visit our website: <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3691592-1&amp;h=941724130&amp;u=https%3A%2F%2Fwww.weisslaw.co%2Fnews-and-cases%2Fbtrs&amp;a=https%3A%2F%2Fwww.weisslaw.co%2Fnews-and-cases%2Fbtrs\" target=\"_blank\" rel=\"nofollow noopener\">https:\/\/www.weisslaw.co\/news-and-cases\/btrs<\/a><\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=DC17732&amp;sd=2022-10-27\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow noopener\" href=\"https:\/\/www.prnewswire.com\/news-releases\/shareholder-alert-weiss-law-reminds-sbtx-rmed-rcor-and-btrs-shareholders-about-its-ongoing-investigations-301661695.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/shareholder-alert-weiss-law-reminds-sbtx-rmed-rcor-and-btrs-shareholders-about-its-ongoing-investigations-301661695.html<\/a><\/p>\n<p>SOURCE  Weiss Law<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=DC17732&amp;Transmission_Id=202210271841PR_NEWS_USPR_____DC17732&amp;DateId=20221027\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire NEW YORK , Oct. 27, 2022 \/PRNewswire\/ &#8212;\u00a0 If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: Joshua Rubin, Esq. Weiss Law305 Broadway, 7th FloorNew York, NY 10007(212)\u00a0682-3025(888) 593-4771stockinfo@weisslawllp.com Silverback Therapeutics, Inc. (NASDAQ: SBTX) Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Silverback Therapeutics, Inc. (NASDAQ: SBTX), in connection with SBTX&#8217;s proposed merger with ARS Pharmaceuticals, Inc. (&#8220;ARS&#8221;). Under the terms of the merger agreement, assuming that SBTX&#8217;s net cash at closing is $240 million, SBTX\u00a0equity holders are expected to own only approximately &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-weiss-law-reminds-sbtx-rmed-rcor-and-btrs-shareholders-about-its-ongoing-investigations\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;SHAREHOLDER ALERT: Weiss Law Reminds SBTX, RMED, RCOR, and BTRS Shareholders About Its Ongoing Investigations&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-702415","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SHAREHOLDER ALERT: Weiss Law Reminds SBTX, RMED, RCOR, and BTRS Shareholders About Its Ongoing Investigations - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-weiss-law-reminds-sbtx-rmed-rcor-and-btrs-shareholders-about-its-ongoing-investigations\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SHAREHOLDER ALERT: Weiss Law Reminds SBTX, RMED, RCOR, and BTRS Shareholders About Its Ongoing Investigations - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEW YORK , Oct. 27, 2022 \/PRNewswire\/ &#8212;\u00a0 If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: Joshua Rubin, Esq. Weiss Law305 Broadway, 7th FloorNew York, NY 10007(212)\u00a0682-3025(888) 593-4771stockinfo@weisslawllp.com Silverback Therapeutics, Inc. (NASDAQ: SBTX) Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Silverback Therapeutics, Inc. (NASDAQ: SBTX), in connection with SBTX&#8217;s proposed merger with ARS Pharmaceuticals, Inc. (&#8220;ARS&#8221;). Under the terms of the merger agreement, assuming that SBTX&#8217;s net cash at closing is $240 million, SBTX\u00a0equity holders are expected to own only approximately &hellip; Continue reading &quot;SHAREHOLDER ALERT: Weiss Law Reminds SBTX, RMED, RCOR, and BTRS Shareholders About Its Ongoing Investigations&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-weiss-law-reminds-sbtx-rmed-rcor-and-btrs-shareholders-about-its-ongoing-investigations\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-27T22:44:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1424445\/WeissLaw_LLP_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-weiss-law-reminds-sbtx-rmed-rcor-and-btrs-shareholders-about-its-ongoing-investigations\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-weiss-law-reminds-sbtx-rmed-rcor-and-btrs-shareholders-about-its-ongoing-investigations\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"SHAREHOLDER ALERT: Weiss Law Reminds SBTX, RMED, RCOR, and BTRS Shareholders About Its Ongoing Investigations\",\"datePublished\":\"2022-10-27T22:44:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-weiss-law-reminds-sbtx-rmed-rcor-and-btrs-shareholders-about-its-ongoing-investigations\\\/\"},\"wordCount\":507,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-weiss-law-reminds-sbtx-rmed-rcor-and-btrs-shareholders-about-its-ongoing-investigations\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1424445\\\/WeissLaw_LLP_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-weiss-law-reminds-sbtx-rmed-rcor-and-btrs-shareholders-about-its-ongoing-investigations\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-weiss-law-reminds-sbtx-rmed-rcor-and-btrs-shareholders-about-its-ongoing-investigations\\\/\",\"name\":\"SHAREHOLDER ALERT: Weiss Law Reminds SBTX, RMED, RCOR, and BTRS Shareholders About Its Ongoing Investigations - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-weiss-law-reminds-sbtx-rmed-rcor-and-btrs-shareholders-about-its-ongoing-investigations\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-weiss-law-reminds-sbtx-rmed-rcor-and-btrs-shareholders-about-its-ongoing-investigations\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1424445\\\/WeissLaw_LLP_Logo.jpg\",\"datePublished\":\"2022-10-27T22:44:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-weiss-law-reminds-sbtx-rmed-rcor-and-btrs-shareholders-about-its-ongoing-investigations\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-weiss-law-reminds-sbtx-rmed-rcor-and-btrs-shareholders-about-its-ongoing-investigations\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-weiss-law-reminds-sbtx-rmed-rcor-and-btrs-shareholders-about-its-ongoing-investigations\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1424445\\\/WeissLaw_LLP_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1424445\\\/WeissLaw_LLP_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-weiss-law-reminds-sbtx-rmed-rcor-and-btrs-shareholders-about-its-ongoing-investigations\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SHAREHOLDER ALERT: Weiss Law Reminds SBTX, RMED, RCOR, and BTRS Shareholders About Its Ongoing Investigations\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SHAREHOLDER ALERT: Weiss Law Reminds SBTX, RMED, RCOR, and BTRS Shareholders About Its Ongoing Investigations - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-weiss-law-reminds-sbtx-rmed-rcor-and-btrs-shareholders-about-its-ongoing-investigations\/","og_locale":"en_US","og_type":"article","og_title":"SHAREHOLDER ALERT: Weiss Law Reminds SBTX, RMED, RCOR, and BTRS Shareholders About Its Ongoing Investigations - Market Newsdesk","og_description":"PR Newswire NEW YORK , Oct. 27, 2022 \/PRNewswire\/ &#8212;\u00a0 If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: Joshua Rubin, Esq. Weiss Law305 Broadway, 7th FloorNew York, NY 10007(212)\u00a0682-3025(888) 593-4771stockinfo@weisslawllp.com Silverback Therapeutics, Inc. (NASDAQ: SBTX) Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Silverback Therapeutics, Inc. (NASDAQ: SBTX), in connection with SBTX&#8217;s proposed merger with ARS Pharmaceuticals, Inc. (&#8220;ARS&#8221;). Under the terms of the merger agreement, assuming that SBTX&#8217;s net cash at closing is $240 million, SBTX\u00a0equity holders are expected to own only approximately &hellip; Continue reading \"SHAREHOLDER ALERT: Weiss Law Reminds SBTX, RMED, RCOR, and BTRS Shareholders About Its Ongoing Investigations\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-weiss-law-reminds-sbtx-rmed-rcor-and-btrs-shareholders-about-its-ongoing-investigations\/","og_site_name":"Market Newsdesk","article_published_time":"2022-10-27T22:44:05+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1424445\/WeissLaw_LLP_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-weiss-law-reminds-sbtx-rmed-rcor-and-btrs-shareholders-about-its-ongoing-investigations\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-weiss-law-reminds-sbtx-rmed-rcor-and-btrs-shareholders-about-its-ongoing-investigations\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"SHAREHOLDER ALERT: Weiss Law Reminds SBTX, RMED, RCOR, and BTRS Shareholders About Its Ongoing Investigations","datePublished":"2022-10-27T22:44:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-weiss-law-reminds-sbtx-rmed-rcor-and-btrs-shareholders-about-its-ongoing-investigations\/"},"wordCount":507,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-weiss-law-reminds-sbtx-rmed-rcor-and-btrs-shareholders-about-its-ongoing-investigations\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1424445\/WeissLaw_LLP_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-weiss-law-reminds-sbtx-rmed-rcor-and-btrs-shareholders-about-its-ongoing-investigations\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-weiss-law-reminds-sbtx-rmed-rcor-and-btrs-shareholders-about-its-ongoing-investigations\/","name":"SHAREHOLDER ALERT: Weiss Law Reminds SBTX, RMED, RCOR, and BTRS Shareholders About Its Ongoing Investigations - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-weiss-law-reminds-sbtx-rmed-rcor-and-btrs-shareholders-about-its-ongoing-investigations\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-weiss-law-reminds-sbtx-rmed-rcor-and-btrs-shareholders-about-its-ongoing-investigations\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1424445\/WeissLaw_LLP_Logo.jpg","datePublished":"2022-10-27T22:44:05+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-weiss-law-reminds-sbtx-rmed-rcor-and-btrs-shareholders-about-its-ongoing-investigations\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-weiss-law-reminds-sbtx-rmed-rcor-and-btrs-shareholders-about-its-ongoing-investigations\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-weiss-law-reminds-sbtx-rmed-rcor-and-btrs-shareholders-about-its-ongoing-investigations\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1424445\/WeissLaw_LLP_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1424445\/WeissLaw_LLP_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-weiss-law-reminds-sbtx-rmed-rcor-and-btrs-shareholders-about-its-ongoing-investigations\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"SHAREHOLDER ALERT: Weiss Law Reminds SBTX, RMED, RCOR, and BTRS Shareholders About Its Ongoing Investigations"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/702415","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=702415"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/702415\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=702415"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=702415"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=702415"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}